Privia Health Group (NASDAQ:PRVA) Shares Up 3.4% on Analyst Upgrade

Shares of Privia Health Group, Inc. (NASDAQ:PRVAGet Rating) shot up 3.4% on Thursday after Truist Financial raised their price target on the stock from $48.00 to $54.00. Truist Financial currently has a buy rating on the stock. Privia Health Group traded as high as $41.89 and last traded at $41.89. 2,927 shares were traded during trading, a decline of 100% from the average session volume of 1,142,163 shares. The stock had previously closed at $40.51.

Other equities research analysts have also recently issued reports about the company. Credit Suisse Group lifted their target price on Privia Health Group from $33.00 to $41.00 and gave the company an “outperform” rating in a research note on Friday, August 12th. SVB Leerink lifted their target price on Privia Health Group from $33.00 to $46.00 and gave the company an “outperform” rating in a research note on Friday, August 12th. Canaccord Genuity Group lifted their target price on Privia Health Group from $45.00 to $50.00 in a research note on Thursday, August 25th. Cowen lifted their target price on Privia Health Group from $35.00 to $44.00 and gave the company an “outperform” rating in a research note on Friday, August 12th. Finally, Guggenheim lifted their price objective on Privia Health Group from $36.00 to $51.00 and gave the stock a “buy” rating in a research note on Friday, August 12th. Twelve investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $44.58.

Insiders Place Their Bets

In other Privia Health Group news, CEO Matthew Shawn Morris sold 68,102 shares of Privia Health Group stock in a transaction dated Thursday, August 25th. The stock was sold at an average price of $42.20, for a total transaction of $2,873,904.40. Following the transaction, the chief executive officer now directly owns 121,739 shares in the company, valued at $5,137,385.80. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Privia Health Group news, CFO David Mountcastle sold 19,280 shares of Privia Health Group stock in a transaction dated Tuesday, July 5th. The stock was sold at an average price of $30.73, for a total transaction of $592,474.40. Following the transaction, the chief financial officer now directly owns 81,104 shares in the company, valued at $2,492,325.92. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Matthew Shawn Morris sold 68,102 shares of Privia Health Group stock in a transaction dated Thursday, August 25th. The stock was sold at an average price of $42.20, for a total value of $2,873,904.40. Following the transaction, the chief executive officer now owns 121,739 shares in the company, valued at $5,137,385.80. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 662,023 shares of company stock worth $22,218,916. Corporate insiders own 57.60% of the company’s stock.

Institutional Trading of Privia Health Group

Institutional investors have recently modified their holdings of the company. Encompass Wealth Advisors LLC lifted its holdings in shares of Privia Health Group by 37.9% in the first quarter. Encompass Wealth Advisors LLC now owns 18,621 shares of the company’s stock valued at $498,000 after purchasing an additional 5,121 shares in the last quarter. Northern Trust Corp lifted its holdings in shares of Privia Health Group by 63.9% in the fourth quarter. Northern Trust Corp now owns 309,905 shares of the company’s stock valued at $8,017,000 after purchasing an additional 120,807 shares in the last quarter. Qube Research & Technologies Ltd lifted its holdings in shares of Privia Health Group by 120.2% in the fourth quarter. Qube Research & Technologies Ltd now owns 22,648 shares of the company’s stock valued at $586,000 after purchasing an additional 12,361 shares in the last quarter. TD Asset Management Inc. lifted its holdings in shares of Privia Health Group by 5.9% in the first quarter. TD Asset Management Inc. now owns 48,162 shares of the company’s stock valued at $1,287,000 after purchasing an additional 2,680 shares in the last quarter. Finally, PDT Partners LLC lifted its holdings in shares of Privia Health Group by 498.6% in the fourth quarter. PDT Partners LLC now owns 64,047 shares of the company’s stock valued at $1,657,000 after purchasing an additional 53,348 shares in the last quarter. 62.81% of the stock is currently owned by institutional investors.

Privia Health Group Stock Up 4.2 %

The company has a market capitalization of $4.70 billion, a P/E ratio of -91.74 and a beta of 1.06. The business has a fifty day moving average price of $36.43 and a 200 day moving average price of $29.09.

About Privia Health Group

(Get Rating)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

See Also

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.